A dual GIP and GLP-1 receptor agonist peptide supplied as a sterile lyophilized powder for research and formulation development. Each batch is produced under controlled conditions and shipped with a certificate of analysis. Reconstitute in sterile water or buffer per your protocol.
Home / Products / Weight Management & Metabolic Regulation
Weight Management & Metabolic Regulation
Tirzepatide
Synonym(s): LY3298176, GLP-1/GIP dual receptor agonist
- CAS2023788-19-2
- FormulaC225H348N48O68
- Mol. weight4813.45 g/mol
- EC / EINECSNot applicable (synthetic)
Packaging & availability
Pricing on request| Select | SKU | Pack size | Per box | Availability | Price |
|---|---|---|---|---|---|
| TZ05 | 5 mg/vial | 10 vials/box | On request | On request | |
| TZ10 | 10 mg/vial | 10 vials/box | On request | On request | |
| TZ15 | 15 mg/vial | 10 vials/box | On request | On request | |
| TZ30 | 30 mg/vial | 10 vials/box | On request | On request |
Add the sizes you need to a quote request — our team will follow up with pricing and lead time.
| CAS | 2023788-19-2 |
|---|---|
| Linear Formula | C225H348N48O68 |
| Mol. weight | 4813.45 g/mol |
| Purity / Grade | ≥99%, GMP Research Grade, Lyophilized |
| EC / EINECS | Not applicable (synthetic) |
| Synonym(s) | LY3298176, GLP-1/GIP dual receptor agonist |
| Storage | Store at 2–8°C, protect from light |
For research and manufacturing use only. Not for human or veterinary use, diagnosis, or treatment. Supplied to qualified businesses only.
Hazard statements
Always review the Safety Data Sheet before handling. Use appropriate personal protective equipment and follow your facility's chemical hygiene plan.
Download SDS